Multiple Sclerosis (MS) is an inflammatory disease that damages the nerves and affects the transfer of messages between the central nervous system and the rest of the body. It is progressively disabling, impairing mobility and quality of life.
MS is present in all regions of the world, being the estimated prevalence in Europe 108 per 100,000 inhabitants
In the European Union over 400,000 people have Multiple Sclerosis (MS)
Spasticity
54% of patients suffer some degree of spasticity during the first year since diagnosis
Mobility
50% of people with MS have mobility noticeable affected and 15% already require walking aid in the first year of the disease
Fatigue
Within the first year after onset, 81% of patients reported some degree of unexplained fatigue
Cognition
Minimal or mild cognitive impairment was noted by 50% of the patients within the first year with MS
Pain
The pain forces 30% of the patients to change some of their daily activities within the first year of the disease
Less than 50% of persons with multiple sclerosis will be employed 10 years after receiving their diagnosis, and about one-third of them will also need a wheelchair within 20 years after developing multiple sclerosis, according to data published by the Multiple Sclerosis Foundation (USA) 
